Global Oral Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Oral Rabies Vaccine market size was valued at USD 82 million in 2022 and is forecast to a readjusted size of USD 285.2 million by 2029 with a CAGR of 19.4% during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Oral Rabies Vaccine industry chain, the market status of Government (Modified Live Virus, Recombinant Vaccinia), Commercial (Modified Live Virus, Recombinant Vaccinia), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral Rabies Vaccine.

Regionally, the report analyzes the Oral Rabies Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral Rabies Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Oral Rabies Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral Rabies Vaccine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Modified Live Virus, Recombinant Vaccinia).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral Rabies Vaccine market.

Regional Analysis: The report involves examining the Oral Rabies Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral Rabies Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Oral Rabies Vaccine:
Company Analysis: Report covers individual Oral Rabies Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral Rabies Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Government, Commercial).

Technology Analysis: Report covers specific technologies relevant to Oral Rabies Vaccine. It assesses the current state, advancements, and potential future developments in Oral Rabies Vaccine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral Rabies Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Oral Rabies Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    Modified Live Virus
    Recombinant Vaccinia
    Recombinant Adenovirus Vaccine

Market segment by Application
    Government
    Commercial

Major players covered
    Boehringer Ingelheim(Merial)
    Ceva Santé Animale(Artemis Technologies)
    Virbac

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Rabies Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Rabies Vaccine, with price, sales, revenue and global market share of Oral Rabies Vaccine from 2018 to 2023.
Chapter 3, the Oral Rabies Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Rabies Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Rabies Vaccine.
Chapter 14 and 15, to describe Oral Rabies Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oral Rabies Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Oral Rabies Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Modified Live Virus
        1.3.3 Recombinant Vaccinia
        1.3.4 Recombinant Adenovirus Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Oral Rabies Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Government
        1.4.3 Commercial
    1.5 Global Oral Rabies Vaccine Market Size & Forecast
        1.5.1 Global Oral Rabies Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Oral Rabies Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Oral Rabies Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Boehringer Ingelheim(Merial)
        2.1.1 Boehringer Ingelheim(Merial) Details
        2.1.2 Boehringer Ingelheim(Merial) Major Business
        2.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product and Services
        2.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Boehringer Ingelheim(Merial) Recent Developments/Updates
    2.2 Ceva Santé Animale(Artemis Technologies)
        2.2.1 Ceva Santé Animale(Artemis Technologies) Details
        2.2.2 Ceva Santé Animale(Artemis Technologies) Major Business
        2.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product and Services
        2.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
    2.3 Virbac
        2.3.1 Virbac Details
        2.3.2 Virbac Major Business
        2.3.3 Virbac Oral Rabies Vaccine Product and Services
        2.3.4 Virbac Oral Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Virbac Recent Developments/Updates

3 Competitive Environment: Oral Rabies Vaccine by Manufacturer
    3.1 Global Oral Rabies Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Oral Rabies Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Oral Rabies Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Oral Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Oral Rabies Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Oral Rabies Vaccine Manufacturer Market Share in 2022
    3.5 Oral Rabies Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Oral Rabies Vaccine Market: Region Footprint
        3.5.2 Oral Rabies Vaccine Market: Company Product Type Footprint
        3.5.3 Oral Rabies Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Oral Rabies Vaccine Market Size by Region
        4.1.1 Global Oral Rabies Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Oral Rabies Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Oral Rabies Vaccine Average Price by Region (2018-2029)
    4.2 North America Oral Rabies Vaccine Consumption Value (2018-2029)
    4.3 Europe Oral Rabies Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Oral Rabies Vaccine Consumption Value (2018-2029)
    4.5 South America Oral Rabies Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Oral Rabies Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Oral Rabies Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Oral Rabies Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Oral Rabies Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Oral Rabies Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Oral Rabies Vaccine Market Size by Country
        7.3.1 North America Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Oral Rabies Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Oral Rabies Vaccine Market Size by Country
        8.3.1 Europe Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Oral Rabies Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Oral Rabies Vaccine Market Size by Region
        9.3.1 Asia-Pacific Oral Rabies Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Oral Rabies Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Oral Rabies Vaccine Market Size by Country
        10.3.1 South America Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Oral Rabies Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Oral Rabies Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Oral Rabies Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Oral Rabies Vaccine Market Size by Country
        11.3.1 Middle East & Africa Oral Rabies Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Oral Rabies Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Oral Rabies Vaccine Market Drivers
    12.2 Oral Rabies Vaccine Market Restraints
    12.3 Oral Rabies Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Oral Rabies Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Oral Rabies Vaccine
    13.3 Oral Rabies Vaccine Production Process
    13.4 Oral Rabies Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Oral Rabies Vaccine Typical Distributors
    14.3 Oral Rabies Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Oral Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Boehringer Ingelheim(Merial) Basic Information, Manufacturing Base and Competitors
    Table 4. Boehringer Ingelheim(Merial) Major Business
    Table 5. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product and Services
    Table 6. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Boehringer Ingelheim(Merial) Recent Developments/Updates
    Table 8. Ceva Santé Animale(Artemis Technologies) Basic Information, Manufacturing Base and Competitors
    Table 9. Ceva Santé Animale(Artemis Technologies) Major Business
    Table 10. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product and Services
    Table 11. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
    Table 13. Virbac Basic Information, Manufacturing Base and Competitors
    Table 14. Virbac Major Business
    Table 15. Virbac Oral Rabies Vaccine Product and Services
    Table 16. Virbac Oral Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Virbac Recent Developments/Updates
    Table 18. Global Oral Rabies Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 19. Global Oral Rabies Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 20. Global Oral Rabies Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Market Position of Manufacturers in Oral Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 22. Head Office and Oral Rabies Vaccine Production Site of Key Manufacturer
    Table 23. Oral Rabies Vaccine Market: Company Product Type Footprint
    Table 24. Oral Rabies Vaccine Market: Company Product Application Footprint
    Table 25. Oral Rabies Vaccine New Market Entrants and Barriers to Market Entry
    Table 26. Oral Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 27. Global Oral Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 28. Global Oral Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 29. Global Oral Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 30. Global Oral Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 31. Global Oral Rabies Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 32. Global Oral Rabies Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 33. Global Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 34. Global Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 35. Global Oral Rabies Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 36. Global Oral Rabies Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 37. Global Oral Rabies Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 38. Global Oral Rabies Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 39. Global Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 40. Global Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 41. Global Oral Rabies Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 42. Global Oral Rabies Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 43. Global Oral Rabies Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 44. Global Oral Rabies Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 45. North America Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 46. North America Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 47. North America Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 48. North America Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 49. North America Oral Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 50. North America Oral Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 51. North America Oral Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 52. North America Oral Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 53. Europe Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 54. Europe Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 55. Europe Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 56. Europe Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 57. Europe Oral Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 58. Europe Oral Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 59. Europe Oral Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 60. Europe Oral Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 61. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 62. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 63. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 64. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 65. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 66. Asia-Pacific Oral Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 67. Asia-Pacific Oral Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 68. Asia-Pacific Oral Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 69. South America Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 70. South America Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 71. South America Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 72. South America Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 73. South America Oral Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 74. South America Oral Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 75. South America Oral Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 76. South America Oral Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 77. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 78. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 79. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 80. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 81. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 82. Middle East & Africa Oral Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 83. Middle East & Africa Oral Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 84. Middle East & Africa Oral Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 85. Oral Rabies Vaccine Raw Material
    Table 86. Key Manufacturers of Oral Rabies Vaccine Raw Materials
    Table 87. Oral Rabies Vaccine Typical Distributors
    Table 88. Oral Rabies Vaccine Typical Customers
List of Figures
    Figure 1. Oral Rabies Vaccine Picture
    Figure 2. Global Oral Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Oral Rabies Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Modified Live Virus Examples
    Figure 5. Recombinant Vaccinia Examples
    Figure 6. Recombinant Adenovirus Vaccine Examples
    Figure 7. Global Oral Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Oral Rabies Vaccine Consumption Value Market Share by Application in 2022
    Figure 9. Government Examples
    Figure 10. Commercial Examples
    Figure 11. Global Oral Rabies Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Oral Rabies Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Oral Rabies Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Oral Rabies Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Oral Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Oral Rabies Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Oral Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Oral Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Oral Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Oral Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Oral Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Oral Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Oral Rabies Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Oral Rabies Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Oral Rabies Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Oral Rabies Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Oral Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Oral Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Oral Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Oral Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Oral Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Oral Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Oral Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Oral Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Oral Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Oral Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Oral Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Oral Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Oral Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Oral Rabies Vaccine Market Drivers
    Figure 74. Oral Rabies Vaccine Market Restraints
    Figure 75. Oral Rabies Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Oral Rabies Vaccine in 2022
    Figure 78. Manufacturing Process Analysis of Oral Rabies Vaccine
    Figure 79. Oral Rabies Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Companies Mentioned

Boehringer Ingelheim(Merial)
Ceva Santé Animale(Artemis Technologies)
Virbac